Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
15 April 2015Website:
http://www.xbiotech.comNext earnings report:
09 August 2024Last dividends:
15 July 2021Next dividends:
N/APrice
after hours | Fri, 05 Jul 2024 20:02:44 GMTAnalysts recommendations
Institutional Ownership
XBIT Latest News
Findings Show Trends for Reduced Toxicities and Better Outcomes for Subjects Receiving ONIVYDE/5-FU Combination and Targeted anti-IL-1alpha Therapy Findings Show Trends for Reduced Toxicities and Better Outcomes for Subjects Receiving ONIVYDE/5-FU Combination and Targeted anti-IL-1alpha Therapy
What type of business is XBiotech?
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
What sector is XBiotech in?
XBiotech is in the Healthcare sector
What industry is XBiotech in?
XBiotech is in the Biotechnology industry
What country is XBiotech from?
XBiotech is headquartered in United States
When did XBiotech go public?
XBiotech initial public offering (IPO) was on 15 April 2015
What is XBiotech website?
https://www.xbiotech.com
Is XBiotech in the S&P 500?
No, XBiotech is not included in the S&P 500 index
Is XBiotech in the NASDAQ 100?
No, XBiotech is not included in the NASDAQ 100 index
Is XBiotech in the Dow Jones?
No, XBiotech is not included in the Dow Jones index
When does XBiotech report earnings?
The next expected earnings date for XBiotech is 09 August 2024